Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Limin Zhang

Yangtze University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

SEP 7, 2026 · JOURNAL ARTICLE

Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges

Frontiers in Pharmacology

A narrative review synthesizing clinical trial evidence, regulatory approvals, and translational findings to propose a strategic framework for advancing Lu-177 radiopharmaceutical therapy, rather than reporting a primary empirical result.

Expert GuidanceProstate Cancer Treatment and Research Limin Zhang Weirong Shi

Study details

DesignNarrative review

InterventionLu-177–based Radioligand Therapy (RLT), inc…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support